Home | Contact | FAQ | CTSU Members Site

Welcome to the CTSU Public Web Site

GENERAL INFORMATION - Register for access to CTSU  PRESS RELEASES - Cancer Drug Gleevec Improves Recurrence-Free Survival after Surgery for Patients with Primary Gastrointestinal Stromal Tumor - Personalized Treatment Trial for Breast Cancer Launched - CTSU Menu Trials Included in Medicare Pilot - Bevacizumab Combined With Chemotherapy Improves... - Bevacizumab Combined With Chemotherapy Prolongs Survival...   - ECOG Trial Prolongs Survival for Patients With Colorectal Cancer   PRESENTATIONS CTSU Overview Presentation (10/2/07) PDF Version Text only version  GUIDES and TRAINING - CTSU Process Checklist - On-Line Education for the Public and Patients - On-Line Training/Education for Healthcare Professionals - CIRB (Central Institutional Review Board) - CIRB - Approved Protocols (for Participating Institutions) - Informed Consent Information  OTHER LINKS - NCI Hurricane Response Efforts - NCI-CTEP Relationship - Events - CTSU Web Site Accessibility

A CTSU TESTIMONIAL The Praxair Cancer Center at Danbury Hospital is dedicated to providing comprehensive cancer care. Committed to quality, the center offers expert diagnosis and treatment by multidisciplinary teams, including a long tradition of participation in cooperative group and pharmaceutical clinical trials. As the oncology research coordinator, I collaborate with the oncology team to identify protocols for our patients. The collection of clinical trials available from the CTSU has allowed us to enhance our research program to better meet the needs of our community cancer center's patient population. I have found the CTSU group and the web site to be an excellent resource in several ways: The comprehensive presentation of both the clinical and regulatory information improves the processes for initial preparation for IRB review and continued protocol maintenance Updates and changes to clinical trials are communicated in a timely manner The help desk responds rapidly and considerately to my questions The data submission tools help with organization of information We look forward to a maintaining our relationship with the CTSU and their high level of commitment to quality cancer care. (Photo left to right: Pat Hough RN, BSN, Manager of the Praxair Cancer Center, Robert Kloss MD, CTSU Principal Investigator, Sue Gran RN, MPH, Oncology Research Coordinator.) [Testimonials Archive]  ABOUT THE CTSU The Cancer Trials Support Unit (CTSU) is a project sponsored by the National Cancer Institute (NCI) for the support of a national network of physicians to participate in NCI-sponsored Phase III cancer treatment trials. The majority of these trials are sponsored by the adult Cooperative Clinical Trials Groups listed here.   ACOSOG - (American College of Surgeons Oncology Group)   CALGB - (Cancer and Leukemia Group B)   ECOG - (Eastern Cooperative Oncology Group)   GOG - (Gynecologic Oncology Group)   NCIC CTG - (National Cancer Institute of Canada Clinical Trials Group)   NCCTG - (North Central Cancer Treatment Group)   NSABP - (National Surgical Adjuvant Breast and Bowel Project)   RTOG - (Radiation Therapy Oncology Group)   SWOG - (Southwest Oncology Group) CTSU Objectives: Increase physician and patient access to NCI-sponsored clinical trials Streamline and standardize trial data collection and reporting Reduce regulatory/administrative burden on investigators participating in NCI-sponsored Cooperative Group clinical trials (phases 1-3) PLEASE NOTE: Cooperative Group sites located within the United States and Canada are currently eligible for participation in the CTSU. In addition, the CTSU is now open to physicians and institutions in the United States who are not affiliated with a Cooperative Group. Click on the tab for Non-Group Investigators for more information.

CTSU PROTOCOLS Here you'll find... Protocol title and abstract Eligibility Checklist & Schema Physician Fact Sheets PowerPoint Presentations       (where available) Accrual Information Cancer Type: All cancer types Breast CancerCNS Metastases (see Metastatic Cancer)CNS Neoplasms (Primary Tumor)CNS PrimaryCarcinoidGI Stromal TumorGastrointestinal CancerGenitourinary CancerGynecologic CancerHead and Neck CancerLeukemiaLung CancerLymphomaMelanomaMetastatic CancerMyelomaNon-TherapeuticSarcoma and/or search by keyword: To search for other cancer protocols, please visit the NCI Cancer.gov web site.  REPORTS CTSU Active Protocol List & Accrual Report: by Cancer Type by Cooperative Group by Protocol Number Disclaimer - The CTSU does not itself provide treatment information to individual patients or their families. For assistance with finding answers to your cancer-related questions, we encourage you to contact the National Cancer Institute's Cancer Information Service (CIS) for personal, confidential help. The CIS is the source for the latest, most accurate cancer information for patients, their families, the general public, and health professionals. To talk with an information specialist, please call 1–800–4–CANCER (1–800–422–6237). For callers with TTY equipment, the number is 1–800–332–8615. CIS information specialists also offer live, online assistance through the LiveHelp® link on the NCI’s Web site (click on “LiveHelp online chat”) or at https://cissecure.nci.nih.gov/livehelp/welcome.asp" on the Internet. Read more...